By Reuters
NYT World
AstraZeneca's diabetes drug Farxiga has become the first in its class to win U.S. approval as a treatment for heart failure, opening up a major new market opportunity outside of the medicine's established field.
Published date: May 6, 2020 at 09:25AM
Reuters
New York Times article
No comments:
Post a Comment